These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 9256156)
1. Enhanced oral absorption and antiviral activity of 1-O-octadecyl-sn-glycero-3-phospho-acyclovir and related compounds in hepatitis B virus infection, in vitro. Hostetler KY; Beadle JR; Kini GD; Gardner MF; Wright KN; Wu TH; Korba BA Biochem Pharmacol; 1997 Jun; 53(12):1815-22. PubMed ID: 9256156 [TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo activity of 1-O-hexadecylpropanediol-3-phospho-ganciclovir and 1-O-hexadecylpropanediol-3-phospho-penciclovir in cytomegalovirus and herpes simplex virus infections. Hostetler KY; Rybak RJ; Beadle JR; Gardner MF; Aldern KA; Wright KN; Kern ER Antivir Chem Chemother; 2001 Jan; 12(1):61-70. PubMed ID: 11437323 [TBL] [Abstract][Full Text] [Related]
3. Antiviral activities of oral 1-O-hexadecylpropanediol-3-phosphoacyclovir and acyclovir in woodchucks with chronic woodchuck hepatitis virus infection. Hostetler KY; Beadle JR; Hornbuckle WE; Bellezza CA; Tochkov IA; Cote PJ; Gerin JL; Korba BE; Tennant BC Antimicrob Agents Chemother; 2000 Jul; 44(7):1964-9. PubMed ID: 10858362 [TBL] [Abstract][Full Text] [Related]
4. 5'-Amino acid esters of antiviral nucleosides, acyclovir, and AZT are absorbed by the intestinal PEPT1 peptide transporter. Han H; de Vrueh RL; Rhie JK; Covitz KM; Smith PL; Lee CP; Oh DM; Sadée W; Amidon GL Pharm Res; 1998 Aug; 15(8):1154-9. PubMed ID: 9706043 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of hepatitis B virus DNA polymerase by enantiomers of penciclovir triphosphate and metabolic basis for selective inhibition of HBV replication by penciclovir. Shaw T; Mok SS; Locarnini SA Hepatology; 1996 Nov; 24(5):996-1002. PubMed ID: 8903366 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of nucleoside analogues than contain silatrane on the basis of the structure of acyclovir (ACV) as novel inhibitors of hepatitis B virus (HBV). Han A; Li L; Qing K; Qi X; Hou L; Luo X; Shi S; Ye F Bioorg Med Chem Lett; 2013 Mar; 23(5):1310-4. PubMed ID: 23369536 [TBL] [Abstract][Full Text] [Related]
7. Cellular uptake mechanism of amino acid ester prodrugs in Caco-2/hPEPT1 cells overexpressing a human peptide transporter. Han HK; Oh DM; Amidon GL Pharm Res; 1998 Sep; 15(9):1382-6. PubMed ID: 9755889 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of hepatitis B virus polymerase-activity by various agents. Transient expression of hepatitis B virus DNA in hepatoma cells as novel system for evaluation of antiviral drugs. Galle PR; Theilmann L Arzneimittelforschung; 1990 Dec; 40(12):1380-2. PubMed ID: 2095136 [TBL] [Abstract][Full Text] [Related]
9. The SATE pronucleotide approach applied to acyclovir: part II. Effects of bis(SATE)phosphotriester derivatives of acyclovir on duck hepatitis B virus replication in vitro and in vivo. Hantz O; Périgaud C; Borel C; Jamard C; Zoulim F; Trépo C; Imbach JL; Gosselin G Antiviral Res; 1999 Jan; 40(3):179-87. PubMed ID: 10027652 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and in vitro activities of a new antiviral duplex drug linking Zidovudine (AZT) and Foscarnet (PFA) via an octadecylglycerol residue. Schott H; Hamprecht K; Schott S; Schott TC; Schwendener RA Bioorg Med Chem; 2009 Jan; 17(1):303-10. PubMed ID: 19010684 [TBL] [Abstract][Full Text] [Related]
11. Alkylthioglycerol prodrugs of foscarnet: synthesis, oral bioavailability and structure-activity studies in human cytomegalovirus-, herpes simplex virus type 1- and human immunodeficiency virus type 1-infected cells. Beadle JR; Kini GD; Aldern KA; Gardner MF; Wright KN; Richman DD; Hostetler KY Antivir Chem Chemother; 1998 Jan; 9(1):33-40. PubMed ID: 9875375 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiviral evaluation of 1-O-hexadecylpropanediol-3-P-acyclovir: efficacy against HSV-1 infection in mice. Beadle JR; Kini GD; Aldern KA; Gardner MF; Wright KN; Rybak RJ; Kern ER; Hostetler KY Nucleosides Nucleotides Nucleic Acids; 2000; 19(1-2):471-9. PubMed ID: 10772728 [TBL] [Abstract][Full Text] [Related]
13. Lipid prodrugs of phosphonoacids: greatly enhanced antiviral activity of 1-O-octadecyl-sn-glycero-3-phosphonoformate in HIV-1, HSV-1 and HCMV-infected cells, in vitro. Hostetler KY; Kini GD; Beadle JR; Aldern KA; Gardner MF; Border R; Kumar R; Barshak L; Sridhar CN; Wheeler CJ; Richman DD Antiviral Res; 1996 Jun; 31(1-2):59-67. PubMed ID: 8793009 [TBL] [Abstract][Full Text] [Related]
14. Novel dipeptide prodrugs of acyclovir for ocular herpes infections: Bioreversion, antiviral activity and transport across rabbit cornea. Anand B; Nashed Y; Mitra A Curr Eye Res; 2003; 26(3-4):151-63. PubMed ID: 12815543 [TBL] [Abstract][Full Text] [Related]
15. In vitro anti-human immunodeficiency virus and anti-hepatitis B virus activities and pharmacokinetic properties of heterodinucleoside phosphates containing AZT or ddC. Peghini PA; Zahner R; Kuster H; Schott H; Schwendener RA Antivir Chem Chemother; 1998 Mar; 9(2):117-26. PubMed ID: 9875383 [TBL] [Abstract][Full Text] [Related]
16. In vitro anti-hepatitis B virus activities of 5"-O-myristoyl analogue derivatives of 3"-fluoro-2",3"-dideoxythymidine (FLT) and 3"-azido-2",3"-dideoxythymidine (AZT). Parang K; Wiebe LI; Knaus EE; Huang JS; Tyrrell DL J Pharm Pharm Sci; 1998; 1(3):108-14. PubMed ID: 10948398 [TBL] [Abstract][Full Text] [Related]
17. In vitro anti-HIV-1 activity of sn-2-substituted 1-O-octadecyl-sn-glycero-3-phosphonoformate analogues and synergy with zidovudine. Hostetler KY; Hammond JL; Kini GD; Hostetler SE; Beadle JR; Aldern KA; Chou TC; Richman DD; Mellors JW Antivir Chem Chemother; 2000 May; 11(3):213-9. PubMed ID: 10901292 [TBL] [Abstract][Full Text] [Related]
18. Novel biotinylated lipid prodrugs of acyclovir for the treatment of herpetic keratitis (HK): transporter recognition, tissue stability and antiviral activity. Vadlapudi AD; Vadlapatla RK; Earla R; Sirimulla S; Bailey JB; Pal D; Mitra AK Pharm Res; 2013 Aug; 30(8):2063-76. PubMed ID: 23657675 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiviral activity of 1-O-octadecyl-2-O-alkyl-sn-glycero-3-foscarnet conjugates in human cytomegalovirus-infected cells. Kini GD; Hostetler SE; Beadle JR; Aldern KA Antiviral Res; 1997 Nov; 36(2):115-24. PubMed ID: 9443668 [TBL] [Abstract][Full Text] [Related]
20. The S-acyl-2-thioethyl pronucleotide approach applied to acyclovir: part I. Synthesis and in vitro anti-hepatitis B virus activity of bis(S-acyl-2-thioethyl)phosphotriester derivatives of acyclovir. Périgaud C; Gosselin G; Girardet JL; Korba BE; Imbach JL Antiviral Res; 1999 Jan; 40(3):167-78. PubMed ID: 10027651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]